Call Us 080-41656200 (Mon-Sat: 10AM-8PM)
Free Shipping above Rs. 1499
Cash On Delivery*

Platinum Resistance in Ovarian Cancer

 

Marketed By :  LAP LAMBERT Academic Publishing   Sold By :  Kamal Books International  
Delivery in :  10-12 Business Days

 

Check Your Delivery Options

 
Rs. 5,886

Availability: In stock

 
  • Product Description
 

Ovarian cancer is the leading cause of death from gynecologic malignancy in the United Kingdom and the 4th most common cause of cancer mortality in women. Approximately 1 in 48 women in the UK will develop ovarian cancer in their lifetime. Surgery followed by chemotherapy involving a platinum-containing compound is the standard treatment for advanced disease. However, despite initial response rates of 70% to platinum-based chemotherapy, chemoresistance frequently develops and is in part responsible for the poor 5-year survival rate of just 30%. In this book, the role of the AKT pathway is examined in acquired platinum resistance using three isogenically matched cell line pairs derived from ovarian cancer patients, pre- and post-platinum resistant relapse. Findings here provide evidence for the role of DNA-PKcs in mediating the activation of AKT in response to DNA DSBs caused by the cytotoxic effects of cisplatin, which is observed in platinum-resistant ovarian cancer cell lines, but not platinum-sensitive cell lines. Targeting DNA-PKcs, in combination with platinum, presents a novel strategy of reversing platinum resistance and circumventing insulin-related toxicities.

Product Specifications
SKU :COC97725
AuthorMichelle Chen
LanguageEnglish
BindingPaperback
Number of Pages296
Publishing Year2011-07-28T00:00:00.000
ISBN978-3844396287
Edition1 st
Book TypeBiology, life sciences
Country of ManufactureIndia
Product BrandLAP LAMBERT Academic Publishing
Product Packaging InfoBox
In The Box1 Piece
Product First Available On ClickOnCare.com2015-08-18 00:00:00